Pipeline Database
UB668
Search clinical-stage assets by therapeutic area, modality, target, indication, stage and territory — then inquire on any row that fits your brief.
UB668
IndicationsPulmonary fibrosis
ClinicalCN - Preclinical
TherapeuticsRespiratory
ModalitiesNucleic Acid Therapeutics
Exclusive Summary
- Poised to become a first-in-class siRNA therapeutic for the treatment of idiopathic pulmonary fibrosis (IPF)
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →